GENB Generate Biomedicines, Inc.

NASDAQ
$10.38

Generate Biomedicines, Inc. (GENB) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus GENB's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 1 seller in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
1
1 transaction
Purchases
$0
0 shares
Sales
$184.7K
11,409 shares
Net activity
-$184.7K
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $184.7K 1 transaction · 11,409 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $184.7K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: March 4, 2026 , by Nally Michael .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
ARNOLD FRANCES Director Sell 10b5-1 11,409 $16.19 $184.7K 220,063 −4.9% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.